Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...
Zacks Investment Research on MSN2d
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on ItEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
A new kind of pharma-telehealth partnership has come under scrutiny over concerns that such an arrangement could lead to ...
After failing to pass muster with England’s drug reimbursement watchdog earlier this month, Eli Lilly’s Alzheimer’s disease ...
The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...
Pressure may grow on companies to repatriate production, raising production costs and potentially medicine prices too.
President Donald Trump’s tariffs on pharmaceuticals "to come at some point" as companies promise to build infrastructure in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback